You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cetuximab

Showing 1 - 25 of 558
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer, Cetuximab, Skin Toxicity Trial in Guangzhou (Crisaborole Ointment, Cetuximab)

Recruiting
  • Metastatic Colorectal Cancer
  • +2 more
  • Crisaborole Ointment
  • Cetuximab
  • Guangzhou, Guangdong, China
    WeiWei Xiao
Nov 3, 2023

Squamous Cell Carcinoma of the Head and Neck Trial (Xevinapant, Placebo, cetuximab)

Not yet recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • (no location specified)
Jul 3, 2023

Metastatic Colorectal Cancer Trial in Houston (Cetuximab, Ulixertinib, Encorafenib)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Cetuximab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 9, 2023

Metastatic Colorectal Adenocarcinoma, Refractory Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8 Trial (drug,

Not yet recruiting
  • Metastatic Colorectal Adenocarcinoma
  • +2 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +6 more
  • (no location specified)
Oct 25, 2023

Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable Trial in Guangzhou (Cetuximab, Zimberelimab, Docetaxel)

Not yet recruiting
  • Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable
  • Cetuximab
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University
Oct 24, 2023

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

Not yet recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Cetuximab
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 2, 2023

Head Neck, Squamous Cell Carcinoma of Head and Neck Trial in Houston (Pembrolizumab, Magrolimab, cetuximab)

Not yet recruiting
  • Head Neck
  • Squamous Cell Carcinoma of Head and Neck
  • Houston, Texas
    M D Anderson Cancer Center
Sep 14, 2023

Colorectal Cancer Liver Metastases Trial in Shanghai (Cetuximab)

Not yet recruiting
  • Colorectal Cancer Liver Metastases
  • Cetuximab
  • Shanghai, Shanghai, China
  • +1 more
May 22, 2023

Colorectal Cancer Trial (Tislelizumab, Irinotecan Hydrochloride, cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Mar 23, 2023

Advanced or Metastatic Squamous NSCLC Trial in Sydney (HMBD-001, Docetaxel, Cetuximab)

Not yet recruiting
  • Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
  • Sydney, New South Wales, Australia
    GenesisCare North Shore
Jun 20, 2023

Advance NSCLC Trial (GFH925, Cetuximab)

Not yet recruiting
  • Advance Non-small Cell Lung Cancer
  • (no location specified)
Mar 7, 2023

Metastatic Colorectal Cancer Trial in Guangzhou (Cetuximab, Capecitabine)

Recruiting
  • Metastatic Colorectal Cancer
  • Guangzhou, Guangdong, China
    The Sixth Affiliated Hospital of Sun Yat-sen University
Mar 7, 2023

Colorectal Cancer, NSCLC Trial (GDC-1971, Osimertinib, Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • Non-Small Cell Lung Cancer
  • (no location specified)
Jul 12, 2023

Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck Trial in Madison (Cetuximab, Imatinib)

Recruiting
  • Head and Neck Cancer
  • Squamous Cell Carcinoma of Head and Neck
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Apr 24, 2023

Colon Adenocarcinoma, Microsatellite Stable Colon Carcinoma, Stage IIB Colon Cancer AJCC v8 Trial (drug, biological, procedure,

Not yet recruiting
  • Colon Adenocarcinoma
  • +4 more
  • (no location specified)
Jan 24, 2023

Colon Cancer, Colorectal Cancer Trial in Houston (MRTX849, Irinotecan, Cetuximab)

Not yet recruiting
  • Colon Cancer
  • Colorectal Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2023

Colorectal Cancer Trial (SOT101, Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Dec 5, 2022

Cancer of Colon Trial in Jerusalem (Cetuximab)

Terminated
  • Cancer of Colon
  • Cetuximab
  • Jerusalem, Israel
    Hadassah Ein Kerem
Aug 2, 2022

Metastatic Colorectal Cancer Trial (ZN-c3, Encorafenib, Cetuximab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • (no location specified)
Feb 15, 2023

Squamous Cell Cancers of the Head and Neck Trial in New Haven (cetuximab, afatinib)

Recruiting
  • Squamous Cell Cancers of the Head and Neck
  • New Haven, Connecticut
    Yale Cancer Center
Jan 10, 2023

Metastatic Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8 Trial in Houston

Active, not recruiting
  • Metastatic Colorectal Carcinoma
  • +4 more
  • Cetuximab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 4, 2022

Recurrent Head Neck Cancer, Head Neck Cancer, Head and Neck Tumors Trial in Cincinnati (Durvalumab, Cetuximab)

Active, not recruiting
  • Recurrent Head and Neck Cancer
  • +3 more
  • Cincinnati, Ohio
    UC Health
Oct 3, 2022

Carcinoma, Squamous Cell of Head and Neck Trial in United States (Cetuximab, PD 0332991)

Active, not recruiting
Has Results
  • Carcinoma, Squamous Cell of Head and Neck
  • Cetuximab
  • PD 0332991
  • Atlanta, Georgia
  • +4 more
Nov 1, 2022

Head Neck Cancer, Locally Advanced Trial in Bangkok (Palbociclib, Cetuximab, Intensity Modulated Radiation Therapy)

Active, not recruiting
  • Head and Neck Cancer
  • Locally Advanced
  • Bangkok, Thailand
    Faculty of Medicine, Ramathibodi Hospital
Sep 19, 2022

Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Oral Cavity

Active, not recruiting
Has Results
  • Squamous Cell Carcinoma of the Oropharynx
  • +7 more
  • Tampa, Florida
  • +2 more
Dec 30, 2022